Regular Article
Genetic aspects of ankylosing spondylitis

https://doi.org/10.1053/berh.2002.0243Get rights and content

Abstract

There is substantial evidence strongly favouring a direct role for HLA-B27 in genetic susceptibility to ankylosing spondylitis (AS) and related spondyloarthropathies (SpA), although the underlying molecular basis has yet to be identified. HLA-B27 itself is a serologic specificity that encompasses 26 different alleles that encode 24 different subtypes – HLA-B*2701 to B*2725, with the exclusion of B*2722. [TheB*2722 allele was deleted as an official WHO allele in April 2002, with a note that the reference cell has been shown to have the same sequence as B*2706. Thus, from now on, with this deletion of B*2722, there will be a “hole” among the HLA-B*2701 to B*2725 group of alleles]. The 24 HLA-B27 alleles (subtypes) seem to have evolved from the most widespread subtype, B*2705. Two B27 alleles have been reported to lack association with AS: B*2706 among Southeast Asian populations, and B*2709 among Sardinians. The distinction between the disease-associated subtypes and those that are not disease-associated may provide some clues to the actual role of HLA-B27 in disease pathogenesis. Genetic family studies in populations of European descent indicate that HLA-B27 contributes only 16 % of the total genetic risk for the disease. The genes in the Major Histocompatibility Complex (MHC) as a whole, that includes HLA-B27, account for about half of the genetic susceptibility for AS. This clearly indicates the presence of additional disease predisposing genes in the MHC region on chromosome 6, and genome-wide studies have identified many areas of interest on other chromosomes that may contain additional disease predisposing genes. Additional studies emanating from the recent mapping of the human genome is expected to lead to better understanding of the genetic basis of these and other rheumatic diseases. Genetic counselling and the use of HLA-B27 typing as an aid to diagnosis are also reviewed.

References (69)

  • M Rudwaleit et al.

    Cytokine gene polymorphisms relevant to spondyloarthropathies

    Current Opinion in Rheumatology

    (2001)
  • EA Carswell et al.

    An endotoxin-induced factor that causes necrosis of tumors

    Proceedings of the National Academy of Sciences of the USA

    (1975)
  • G MGM Verjans et al.

    Restriction fragment length polymorphisms of the tumor necrosis factor region in patients with ankylosing spondylitis

    Arthritis & Rheumatism

    (1991)
  • G MGM Verjans et al.

    Polymorphisms of tumour necrosis factor-alpha (TNF-a) at position −308 in relation to ankylosing spondylitis

    Clinical and Experimental Immunology

    (1994)
  • F McGarry et al.

    The −308 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA B27

    Journal Rheumatology

    (1999)
  • A Milicic et al.

    Interpreting studies of TNF polymorphisms confirms the presence of a second MHC susceptibility locus in ankylosing spondylitis

    Genes and Immunity

    (2000)
  • MA Brown et al.

    The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis

    Arthritis & Rheumatism

    (1998)
  • R Said-Nahal et al.

    The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families

    Ann Rheum Dis

    (2002)
  • WP Maksymowych et al.

    LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis

    Journal of Rheumatology

    (2000)
  • JD Reveille et al.

    Evidence for a second major histocampatibility complex (MHC) in predisposition to familial ankylosing spondylitis (AS) (abstract #1116)

    Arthritis & Rheumatism

    (2001)
  • MA Brown et al.

    Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis

    Human Molecular Genetics

    (2000)
  • MD Collado-Escobar et al.

    Interleukin 6 gene promoter polymorphism is not associated with ankylosing spondylitis

    Journal of Rheumatology

    (2000)
  • P Baudoin et al.

    Increased risk of developing ankylosing spondylitis among first-born children

    Arthritis & Rheumatism

    (2000)
  • E Hoyle et al.

    The X-chromosome and susceptibility to ankylosing spondylitis

    Arthritis & Rheumatism

    (2000)
  • K Mori et al.

    Polymorphic CAG repeats of the androgen receptor gene in Japanese male patients with ankylosing spondylitis

    Rheumatology (Oxford)

    (2000)
  • PJ Bjorkman et al.

    Structure of the human class I histocompatibility antigen, HLA-A2

    Nature

    (1987)
  • PJ Bjorkman et al.

    The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens

    Nature

    (1987)
  • TS Jardetzky et al.

    Identification of self peptides bound to purified HLA-B27

    Nature

    (1991)
  • TP Garrett et al.

    Specificity pockets for the side chains of peptide antigens in HLAw68

    Nature

    (1989)
  • M Matsumura et al.

    Emerging principles for the recognition of peptide antigens by MHC class I molecules

    Science

    (1992)
  • Edward Ball et al.

    HLA-B27 polymorphism

    Bone Joint Spine

    (2001)
  • I Alvarez et al.

    HLA-B27 and immunogenetics of spondyloarthropathies

    Current Opinion in Rheumatology

    (2000)
  • JR Lamas et al.

    Modulation at multiple anchor positions of the peptide specificity of HLA-B27 subtypes differentially associated with ankylosing spondylitis

    Arthritis & Rheumatism

    (1999)
  • S Rojo et al.

    Structural analysis of an HLA-B27 population variant, B27f. Multiple patterns of amino acid changes within a single polypeptide segment generate polymorphism in HLA-B27

    Journal of Immunology

    (1987)

    • Cited by (97)

    • Microbes, helminths, and rheumatic diseases

      2020, Best Practice and Research: Clinical Rheumatology

    • Diagnostic contribution of HLA-A, B, C, DR genotyping in inflammatory joint disease

      2018, Revue du Rhumatisme (Edition Francaise)

    • Contribution of ancient human remains analysis to the understanding of the variability in HLA-B gene variants in relation to the diagnosis of spondyloarthropathies

      2018, Journal of Autoimmunity
      Citation Excerpt :

      In the DNAzol method, the sample is incubated and stirred for 3 days in the dark with DNAzol, which contains guanidine thiocyanate (GuSCN) and the supernatant obtained is concentrated and purified using purification columns with silica base (PCR Purification Kit by QIAgen) [25,26]. The HLA-B gene shows a high degree of genetic polymorphism, mainly located in exons 2 and 3 of its eight exons [27–29]. There are hundreds of HLA-B alleles, defined according to the differences in the nucleotide sequence [29,30].

    • Diagnostic contribution of HLA-A,B,C,DR genotyping in inflammatory joint disease

      2018, Joint Bone Spine

    • HLA-B*27 subtypes and their implications in the pathogenesis of ankylosing spondylitis

      2018, Gene
      Citation Excerpt :

      In addition, HLA-B*27:05:02 is identical with HLA-B*27:13, except in the gene leader segment, which is not expressed on the cell surface. Therefore, both alleles of HLA-B*27:05:02 and HLA-B*27:13, encode the same HLA-B*27 molecule (Khan and Ball, 2002). HLA-B*27:06, which has no association with AS, varies from HLA-B*27:04 by only two amino acids substitution, including residues of position 114 (His to Asp) and position 116 (Asp to Tyr).

    • TNF-α-308 polymorphism determines clinical manifestations and therapeutic response of ankylosing spondylitis in Han Chinese

      2017, Medicina Clinica
    View all citing articles on Scopus
    View full text
    Copyright © 2002 Elsevier Science Ltd. All rights reserved.